Validation of a case definition for osteoporosis disease surveillance
- PMID: 20458577
- DOI: 10.1007/s00198-010-1225-2
Validation of a case definition for osteoporosis disease surveillance
Abstract
A simple case definition for osteoporosis case diagnosis is feasible based upon administrative health data. This may facilitate implementation of a population-based osteoporosis surveillance program, providing information that could help to inform and guide screening, prevention, and treatment resources.
Introduction: Our aim was to construct and validate a simplified algorithm for osteoporosis case ascertainment from administrative databases that would be suitable for disease surveillance.
Methods: Multiple classification rules were applied to different sets of hospital diagnosis, physician claims diagnosis, and prescription drug variables from Manitoba, Canada. Algorithms were validated against results from a regional bone mineral density testing program that identified bone mineral density (BMD) measurements in 4,015 women age 50 years and older with at least one BMD test between April 1, 2000 and March 31, 2001.
Results: Sensitivity as high as 93.3% was achieved with 3 years of data. Specificity ranged from 50.8% to 91.4% overall, and from 81.2% to 99.1% for discriminating osteoporotic from normal BMD. Sensitivity and overall accuracy were generally lower for algorithms based on diagnosis codes alone than for algorithms that included osteoporosis prescriptions. In the subgroup without prior osteoporotic fractures or chronic corticosteroid use, one simple algorithm (one hospital diagnosis, physician claims diagnosis, or osteoporosis prescription within 1 year) gave accuracy measures exceeding 90% for discriminating osteoporosis from normal BMD across a wide range of disease prevalence.
Conclusions: A relatively simple case definition for osteoporosis surveillance based upon administrative health data can achieve an acceptable level of sensitivity, specificity, and accuracy. Performance is enhanced when the case definition includes osteoporosis medication use in the formulation.
Similar articles
-
Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases.J Clin Epidemiol. 2008 Dec;61(12):1250-1260. doi: 10.1016/j.jclinepi.2008.02.002. Epub 2008 Jul 10. J Clin Epidemiol. 2008. PMID: 18619800
-
Postfracture care for older women: gaps between optimal care and actual care.Can Fam Physician. 2008 Sep;54(9):1270-6. Can Fam Physician. 2008. PMID: 18791104 Free PMC article.
-
Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95. doi: 10.1002/pds.1068. Pharmacoepidemiol Drug Saf. 2005. PMID: 15645517
-
Bone Density Screening and Re-screening in Postmenopausal Women and Older Men.Curr Osteoporos Rep. 2015 Dec;13(6):390-8. doi: 10.1007/s11914-015-0289-5. Curr Osteoporos Rep. 2015. PMID: 26408154 Free PMC article. Review.
-
The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.Pharmacoeconomics. 2007;25(11):913-33. doi: 10.2165/00019053-200725110-00003. Pharmacoeconomics. 2007. PMID: 17960951 Review.
Cited by
-
Prevalence of High-Burden Medical Conditions Among Young and Middle-Aged Adults With Pediatric-Onset Medical Conditions: Findings From US Private and Public Administrative Claims Data.Int J Health Policy Manag. 2019 Nov 1;8(11):629-635. doi: 10.15171/ijhpm.2019.62. Int J Health Policy Manag. 2019. PMID: 31779288 Free PMC article.
-
Automating case definitions using literature-based reasoning.Appl Clin Inform. 2013 Oct 30;4(4):515-27. doi: 10.4338/ACI-2013-04-RA-0028. eCollection 2013. Appl Clin Inform. 2013. PMID: 24454579 Free PMC article.
-
Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over.Osteoporos Int. 2013 Sep;24(9):2483-92. doi: 10.1007/s00198-013-2321-x. Epub 2013 Mar 16. Osteoporos Int. 2013. PMID: 23504029
-
Racial differences in skeletal fragility but not osteoarthritis among women and men with cerebral palsy.Bone Rep. 2019 Jul 30;11:100219. doi: 10.1016/j.bonr.2019.100219. eCollection 2019 Dec. Bone Rep. 2019. PMID: 31417943 Free PMC article.
-
Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts.Osteoporos Int. 2011 Oct;22(10):2633-43. doi: 10.1007/s00198-010-1516-7. Epub 2011 Jan 11. Osteoporos Int. 2011. PMID: 21305268
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous